8.12.2024 ASCO Applauds Senate for Prioritizing Cancer Research in FY 2025

The Association for Clinical Oncology (ASCO) is applauding the Senate Appropriations Committee for its bipartisan support of federal cancer research in the fiscal year (FY) 2025 Labor, Health and Human Services, Education, and Related Agencies spending bill.

For FY 2025, the Senate is allocating $48.851 billion for the National Institutes of Health (NIH), a $1.77 billion increase over FY 2024 funding. The bill includes funding for the 21st Century Cures Act, averting and reversing scheduled cuts.

For the National Cancer Institute (NCI), appropriators allocated $7.49 billion, and called for restoring $216 million in funding for the Cancer Moonshot.